Arcus Biosciences, Inc. (RCUS) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arcus Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.873 Hello everyone. Thank you for joining us and welcome to the ARCIS second quarter 2026 00:00:05.873 -- 00:00:11.055 earnings call. After today's prepared remarks, we will host a question and answer 00:00:11.055 -- 00:00:12.476 session. 00:00:12.476 -- 00:00:18.518 If you would like to ask a question, please press star 1 to raise your hand. 00:00:18.518 -- 00:00:22.759 To withdraw your question, press star 1 again. 00:00:22.759 -- 00:00:28.342 I will now hand the conference over to Pia Eaves, Vice President of Investor Relations. 00:00:28.342 -- 00:00:31.222 Pia, please go ahead. 00:00:32.201 -- 00:00:37.023 Good afternoon and thank you for joining us on today's conference call to discuss ARCISO's 00:00:37.023 -- 00:00:41.324 second quarter 2026 financial results and pipeline updates. 00:00:41.324 -- 00:00:45.365 I'd like to remind you that on this call, management will make forward-looking statements, 00:00:45.365 -- 00:00:50.187 including statements about our development strategies and our expectations regarding 00:00:50.187 -- 00:00:54.608 the advantages and opportunities afforded by our investigational products, our clinical 00:00:54.608 -- 00:00:59.868 development milestones and timelines, our projected cash runway, and our financial outlook. 00:00:59.868 -- 00:01:03.772 All statements other than historical facts reflect the current beliefs and expectations 00:01:03.772 -- 00:01:08.255 of management and involve risks and uncertainties that may cause our actual results to 00:01:08.255 -- 00:01:12.299 differ from those expressed. Those risks and uncertainties are described in our most 00:01:12.299 -- 00:01:17.003 recent quarterly report on Form 10-Q that has been filed with the SEC. 00:01:17.003 -- 00:01:21.447 For today's call, p...